Literature DB >> 9341869

Major histocompatibility complex (MHC) class III genetics in two Amerindian tribes from southern Brazil: the Kaingang and the Guarani.

S Weg-Remers1, M Brenden, E Schwarz, K Witzel, P M Schneider, L K Guerra, I R Rehfeldt, M T Lima, D Hartmann, M L Petzl-Erler, I J de Messias, G Mauff.   

Abstract

Population genetic studies of the major histocompatibility complex (MHC) class III region, comprising C2, BF and C4 phenotypes, and molecular genetic data are rarely available for populations other than Caucasoids. We have investigated three Amerindian populations from Southern Brazil: 131 Kaingang from Ivaí (KIV), 111 Kaingang (KRC) and 100 Guarani (GRC) from Rio das Cobras. Extended MHC haplotypes were derived after standard C2, BF, C4 phenotyping and restriction fragment length polymorphism (RFLP) analysis with TaqI, together with HLA data published previously by segregation analysis. C2 and BF frequencies corresponded to other Amerindian populations. C4B*Q0 frequency was high in the GRC (0.429) but low in the Kaingang. Unusual C4 alleles were found, viz. C4A*58, A*55 and C4B*22 (presumably non-Amerindian) and aberrant C4A*3 of Amerindian origin occurring with a frequency of 0.223 in the GRC. C4A*3 bands of homo- and heterozygous individuals carrying this variant were Rodgers 1 positive and Chido 1,3 positive, showed a C4A specific lysis type and a C4A like alpha-chain. Polymerase chain reaction studies and sequencing showed that this is based on a C4A*3 duplication with a regular C4A*3 and a partially converted C4A*0304 carrying the C4B specific epitopes Ch 6 and Ch 1,3. Associations of class III haplotypes with particular RFLP patterns were similar to those reported for Caucasoids. The previously described association between combined C4A and CYP21P deletions and the 6.4 kb TaqI fragment was not seen in these Amerindians. This fragment occurred within a regular two locus gene structure in the Kaingang, representing a "short" gene at C4 locus I. C4 and CYP21 duplications were frequently observed. The distribution of extended MHC haplotypes provides evidence for a close relationship between the KIV and KRC and a larger genetic distance between the two Kaingang groups and the GRC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9341869     DOI: 10.1007/s004390050550

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  5 in total

1.  Complement 4 phenotypes and genotypes in Brazilian patients with classical 21-hydroxylase deficiency.

Authors:  G Guerra-Junior; A Sevciovic Grumach; S H Valente de Lemos-Marini; M Kirschfink; A Condino Neto; M de Araujo; M Palandi De Mello
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

2.  Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins.

Authors:  Erwin K Chung; Yan Yang; Kristi L Rupert; Karla N Jones; Robert M Rennebohm; Carol A Blanchong; C Yung Yu
Journal:  Am J Hum Genet       Date:  2002-09-10       Impact factor: 11.025

3.  Autosomal, mtDNA, and Y-chromosome diversity in Amerinds: pre- and post-Columbian patterns of gene flow in South America.

Authors:  N R Mesa; M C Mondragón; I D Soto; M V Parra; C Duque; D Ortíz-Barrientos; L F García; I D Velez; M L Bravo; J G Múnera; G Bedoya; M C Bortolini; A Ruiz-Linares
Journal:  Am J Hum Genet       Date:  2000-10-13       Impact factor: 11.043

4.  Celiac disease in native Indians from Brazil: A clinical and epidemiological survey.

Authors:  Shirley Ramos da Rosa Utiyama; João Luis Coelho Ribas; Renato Mitsunori Nisihara; Lorete Maria da Silva Kotze; Iara José de Messias-Reason
Journal:  N Am J Med Sci       Date:  2010-03

5.  A globally occurring indel polymorphism in the promoter of the IFNA2 gene is not associated with severity of malaria but with the positivity rate of HCV.

Authors:  Cristina Tena-Tomás; Iara de Messias-Reason; Le H Song; Jürgen Tomiuk; Peter G Kemsner; Jürgen F J Kun
Journal:  BMC Genet       Date:  2008-12-03       Impact factor: 2.797

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.